Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
26.57
+0.21 (0.80%)
Dec 5, 2025, 4:00 PM EST - Market closed
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Pelthos Therapeutics stock ranges from a low of $50 to a high of $60. The average analyst price target of $56 forecasts a 110.76% increase in the stock price over the next year.
Price Target: $56.00 (+110.76%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 3 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +88.18% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +125.82% | Dec 3, 2025 |
| Roth Capital | Roth Capital | Strong Buy Initiates $57 | Strong Buy | Initiates | $57 | +114.53% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $57 | Buy | Reiterates | $50 → $57 | +114.53% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +88.18% | Sep 2, 2025 |
Financial Forecast
Revenue This Year
12.66M
Revenue Next Year
46.26M
from 12.66M
Increased by 265.40%
EPS This Year
-17.19
from -14.27
EPS Next Year
-4.91
from -17.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 20.8M | 76.5M | ||||
| Avg | 12.7M | 46.3M | ||||
| Low | 5.5M | 26.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 504.5% | ||||
| Avg | - | 265.4% | ||||
| Low | - | 105.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -15.42 | -0.58 | ||||
| Avg | -17.19 | -4.91 | ||||
| Low | -18.63 | -11.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.